gene therapy - search results

Low vision can be a blight on the lives of those it affects, which is why it’s a National Eye Institute priority, as Dr Cheri Wiggs told Open Access Government Around 4.2 million people in America are visually impaired, which is expected to increase to 7.2 million in 2030. Of...

The Orkdal model of cancer care rests on collaboration between specialist oncology and community care in palliative treatment, as Anne Kari Knudsen explains The Norwegian Orkdal model of cancer care has been called “the future of cancer care”. The aim is to develop and implement a model for optimal cancer...

Vytenis Andriukaitis, EU Commissioner for Health and Food Safety, stresses the need for prevention and spotlights joint efforts to tackle rare forms of cancer The EU vs. cancer battle has been underway for 32 years – more than half of my lifetime. Since the Heads of State of the European...

Dr Ramón Cacabelos, President of EuroEspes Biomedical Research Center, highlights the potential benefits of novel nutraceuticals including ProteoLipins Pharmacotherapy is a fundamental cornerstone in the global fight against disease worldwide. The value of drug production has grown four times more rapidly than the world’s income. High-income countries dominate in world...

Ahead of World AIDS Day on 1 December, the World Health Organization has released new guidelines on HIV self-testing to improve access to HIV diagnosis According to a WHO progress report published this week, lack of diagnosis for HIV is one of the major obstacles that stands in the way...

Jo Vandesompele, Chief Scientific Officer at Biogazelle, outlines how non-coding RNA research for cancer can help develop a more targeted treatment approach  DNA is the hereditary code that is passed on from parents to their children. Every cell inside our body has the same code that contains the blueprint of...

Gunnar Kristensen, from the Department of Gynaecologic Oncology at Oslo University Hospital, looks at new strategies for the treatment of ovarian cancer. It is recognised that the disease we usually call ovarian cancer can originate from either the ovaries, the fallopian tube (the organ bringing the eggs from the ovaries...

Rachel Clark, Health Promotion Manager, at World Cancer Research Fund, sheds light on breast cancer and how to reduce the risks of developing the disease. Breast cancer is the most common cancer in women in the UK. In fact, 1 in 8 women will develop the disease at some stage...

Zhihui Wang1,2 and Vittorio Cristini1,2   outline how they have developed a model to help predict cancer treatment outcomes… The physical properties of a tumour’s microenvironment influence a drug’s ability to penetrate and kill tumour cells. Some of these properties can be potential obstructions to drug diffusion, increasing the tumour’s resistance...

Melinda Kelley from the National Institute on Aging in the US, speaks to Editor Laura Evans about raising awareness of Alzheimer’s disease and how funding for research is allocated to the National Institutes of Health… Alzheimer’s disease is a global health challenge. The most common form of dementia, Alzheimer’s disease,...

Intermediates between patients and therapists “Do you know what it’s like to hear voices, to have fear of death out of a sudden or to feel a deep inner emptiness?” – Doctors, therapists or nurses can rarely answer this question because they cannot fall back on the personal experience of...

Ramón Cacabelos, President, EuroEspes Biomedical Research Center says it is time to rethink the causes and treatments for Parkinson's disease... It is highly unlikely that James Parkinson (1755-1824), who first described the “paralysis agitans” in his ‘An Essay on the Shaking Palsy’ in 1817 (years later rebadged by Jean-Martin Charcot as Parkinson’s...

SIOPE – the European Society for Paediatric Oncology highlights the importance of strengthening collaborations to ensure childhood cancer survivors lead a healthy life… All childhood cancer survivors should be able to lead a normal life. In Europe however, in spite of the increase of the survival rates, many of them...

Cancer is a complex and heterogeneous disease. Despite all efforts to fight cancer, it continues to impact every segment of society. For example, many patients fail conventional cancer therapies, including chemotherapy, radiation, and surgery; and it is still difficult for physicians to predict a treatment outcome with certainty.

Professor Colin J Suckling, Research Professor of Chemistry at the Department of Pure & Applied Chemistry, University of Strathclyde looks at how the recent EU Referendum could impact his institution and research. Like many British academics, the result of the recent referendum on the UK’s place in Europe was a...

Prof. Dr. Albert Sundrum, Head of Department Animal Health and Animal Nutrition at the University of Kassel highlights progress made by the organic dairy sector… The organic dairy sector has been developing rapidly over the last decade. The existence of a premium price reflects (in part), the consumer expectation that...

Terra G. Arnason and Troy A.A. Harkness from the Departments of Medicine, and Anatomy and Cell Biology at the University of Saskatchewan detail current strategies to prevent or reverse multiple drug resistant malignancy… Multiple drug resistance (MDR) can be present from the outset (inherent) or develop (acquired) in response to...

One of the most important activities for HR is Who to put Where in what Role and with what Responsibilities.  And whether you are recruiting, appraising, shuffling or promoting, an insightful and powerful online tool that you might wish to call upon is Profiling.  But at this point, a...

Hande Ozdinler, PhD, Assistant Professor of Neurology, Northwestern University discusses ALS and outlines the strides made in this area... Amyotrophic Lateral Sclerosis (ALS) is one of the most complex diseases of the nervous system, and one that is very special for humankind.   There exists a long-term debate about what makes us...

Prof David Nutt, European Brain Council on the economic impact of poor brain health & how they are calling for new thinking towards how it is treated